PAC-mediated AKI protection is critically mediated but does not exclusively depend on cell-derived microvesicles
Preprint
Abstract
Acute Kidney Injury (AKI) significantly worsens the prognosis of hospitalized patients. In recent years, cell-based strategies have been established as reliable option for improving AKI outcomes in experimental AKI. Own studies focused on so-called Proangiogenic Cells (PACs). Mechanisms that contribute to PAC-mediated AKI protection include production / secretion of extracellular vesicles (MV - microvesicles). In addition, the cells most likely act by paracrinic processes (secretome). The current study evaluated whether AKI may be preventable by the administration of either PAC-derived MV and / or the secretome alone. AKI was induced in male C57/Bl6N mice (8-12 weeks) by bilateral renal ischemia (IRI - 40 minutes). Syngeneic murine PACs were stimulated with either melatonine, Angiopoietin-1 or -2, or with Bone Morphogenetic Protein-5 (BMP-5) for one hour, respectively. PAC-derived MV and the vesicle-depleted supernatant were subsequently collected and i.v. injected post-ischemia. Mice were analyzed 48 hours later. IRI induced significant kidney excretory dysfunction as reflected by higher serum cystatin C levels. The only measure that improved AKI was the injection of MV, collected from native PACs. The following conditions worsened post-ischemic renal function even further: MV+Ang-1, MV+BMP-5, MV+melatonin, and MV+secretome+Ang-1. Together, our data show that PAC-mediated AKI protection substantially depends on the availability of cell-derived MV. However, since previous data showed improved AKI-protection by PACs after cell preconditioning with certain mediators (Ang-1 and -2, melatonine, BMP-5), other than exclusively vesicle-dependent mechanisms must be involved in PAC-mediated AKI protection.Keywords
All Related Versions
- Published version: Nephrology Dialysis Transplantation, 35 (Supplement).
This publication has 27 references indexed in Scilit:
- Endothelial colony‐forming cells and pro‐angiogenic cells: clarifying definitions and their potential role in mitigating acute kidney injuryActa Physiologica, 2017
- Mesenchymal Stem Cell‐Based Therapy for Kidney Disease: A Review of Clinical EvidenceStem Cells International, 2016
- Transplantation of induced pluripotent stem cell-derived renal stem cells improved acute kidney injuryCell & Bioscience, 2015
- From the nephrologist's point of view: diversity of causes and clinical features of acute kidney injuryClinical Kidney Journal, 2015
- Prognosis of AKI in malignant diseases with and without sepsisBMC Anesthesiology, 2013
- Induced Pluripotent Stem Cells without c-Myc Attenuate Acute Kidney Injury via Downregulating the Signaling of Oxidative Stress and Inflammation in Ischemia–Reperfusion RatsCell Transplantation, 2012
- The hormone melatonin stimulates renoprotective effects of “early outgrowth” endothelial progenitor cells in acute ischemic kidney injuryAmerican Journal of Physiology-Renal Physiology, 2012
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic CellsScience, 2007
- Uric Acid Heralds Ischemic Tissue Injury to Mobilize Endothelial Progenitor CellsJournal of the American Society of Nephrology, 2007
- Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioningAmerican Journal of Physiology-Renal Physiology, 2006